| Barreiras, para a notificação pelo pediatra, de maus-tratos infantis JM Pires, MZ Goldani, EM Vieira, TR Nava, L Feldens, K Castilhos, ... Revista Brasileira de Saúde Materno Infantil 5, 103-108, 2005 | 77 | 2005 |
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study M Ansari, PHD Curtis, CRS Uppugunduri, MA Rezgui, T Nava, V Mlakar, ... Oncotarget 8 (53), 90852, 2017 | 52 | 2017 |
| Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections. A report from workshops on supportive care of the Paediatric Diseases … M Ifversen, R Meisel, P Sedlacek, K Kalwak, L Sisinni, D Hutt, ... Frontiers in pediatrics 9, 705179, 2021 | 40 | 2021 |
| Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation T Nava, N Kassir, MA Rezgui, CRS Uppugunduri, P Huezo‐Diaz Curtis, ... British journal of clinical pharmacology 84 (7), 1494-1504, 2018 | 32 | 2018 |
| Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases … T Nava, M Ansari, JH Dalle, CD de Heredia, T Güngör, E Trigoso, ... Bone marrow transplantation 55 (6), 1126-1136, 2020 | 27 | 2020 |
| GSTA1 genetic variants and conditioning regimen: missing key factors in dosing guidelines of busulfan in pediatric hematopoietic stem cell transplantation T Nava, MA Rezgui, CRS Uppugunduri, PHD Curtis, Y Théoret, M Duval, ... Biology of Blood and Marrow Transplantation 23 (11), 1918-1924, 2017 | 26 | 2017 |
| Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study K Ben Hassine, T Nava, Y Théoret, CE Nath, Y Daali, N Kassir, V Lewis, ... CPT: Pharmacometrics & Systems Pharmacology 10 (9), 1043-1056, 2021 | 19 | 2021 |
| Revisão sistemática sobre aspectos metodológicos das pesquisas em atenção primária no Brasil E Harzheim, AT Stein, C Álvarez-Dardet, MTR Cantero, CK Kruse, ... Revista da AMRIGS 49 (4), 248-252, 2005 | 19 | 2005 |
| Genetic susceptibility to hepatic sinusoidal obstruction syndrome in pediatric patients undergoing hematopoietic stem cell transplantation M Ansari, K Petrykey, MA Rezgui, V Del Vecchio, J Cortyl, RO Ralph, ... Biology of Blood and Marrow Transplantation 26 (5), 920-927, 2020 | 15 | 2020 |
| Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary? T Nava, GE Rivard, A Bonnefoy Platelets 29 (2), 148-155, 2018 | 14 | 2018 |
| The analysis of GSTA1 promoter genetic and functional diversity of human populations V Mlakar, PHD Curtis, M Armengol, V Ythier, I Dupanloup, KB Hassine, ... Scientific reports 11 (1), 5038, 2021 | 12 | 2021 |
| Genetic predictors for sinusoidal obstruction syndrome—a systematic review N Waespe, S Strebel, S Jurkovic Mlakar, M Krajinovic, CE Kuehni, T Nava, ... Journal of personalized medicine 11 (5), 347, 2021 | 10 | 2021 |
| The biological and clinical relevance of G protein-coupled receptors to the outcomes of hematopoietic stem cell transplantation: A systematized review H Golay, S Jurkovic Mlakar, V Mlakar, T Nava, M Ansari International journal of molecular sciences 20 (16), 3889, 2019 | 5 | 2019 |
| Is it better to treat adolescents with acute lymphoblastic leukemia as old children or as young adults? M Alves, L Daudt, KLM Mazzucco, A Taniguchi, T Nava, FL Moreno, ... Blood, The Journal of the American Society of Hematology 112 (11), 3968-3968, 2008 | 5 | 2008 |
| Características e fatores de risco para traumas em iatistas adolescentes FS Fernandes, D Blank, T Nava, M Agranonik, MZ Goldani Rev. AMRIGS, 70-74, 2007 | 5 | 2007 |
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies … S Jurkovic Mlakar, SCR Uppugunduri, T Nava, V Mlakar, H Golay, ... Journal of cancer research and clinical oncology, 1-16, 2022 | 4 | 2022 |
| ABO incompatibile graft management in pediatric transplantation A Balduzzi, H Bönig, A Jarisch, T Nava, M Ansari, A Cattoni, G Prunotto, ... Bone marrow transplantation 56 (1), 84-90, 2021 | 4 | 2021 |
| Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT M Ansari, K Petrykey, MA Rezgui, V Del Vecchio, J Cortyl, M Ameur, ... Bone Marrow Transplantation 56 (11), 2697-2704, 2021 | 3 | 2021 |
| Is busulfan clearance different in patients with sickle cell disease? Let’s clear up that case with some controls A Remy, Y Théorêt, M Ansari, H Bittencourt, T Ducruet, T Nava, Y Pastore, ... Journal of Pediatric Hematology/Oncology 43 (6), e867-e872, 2021 | 3 | 2021 |
| Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation CRS Uppugunduri, P Huezo-Diaz Curtis, T Nava, MA Rezgui, V Mlakar, ... The Pharmacogenomics Journal 22 (1), 9-18, 2022 | 2 | 2022 |
